videos

Co-Chief Operating Officer at Altasciences, Marie-Hélène Raigneau, explains how the internal operations structure ensures an easy and streamlined drug development journey for sponsors.

Focused on your needs, our specialists provide appropriate support for precision bioanalysis, and a full range of research services for a wide range of study types — working with you to accelerate development, meet your milestones, and ensure compliant, on-time regulatory submissions for your drug candidates.

At Altasciences, we maintain an unwavering focus on the welfare of the laboratory animals in our care. Our entire preclinical staff is trained in laboratory animal care and focused on animal welfare and environmental enrichment — embracing compassion, sensitivity, and adherence to regulatory guidelines.

Imagine partnering with a team that you trust and telling your story once. Imagine a world where everyone and every project is of equal importance. Just imagine…

Altasciences has significant experience in cannabis, nicotine and tobacco product studies, both in the U.S. and Canada. We are invited members of the CORESTA (Cooperation Center for Scientific Research Relative to Tobacco) subcommittee on Smoking Behavior and Biomarkers, where we actively contribute to white papers concerning the latest requirements for clinical pharmacology studies needed for regulatory submission.

Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives — working with you to leverage preclinical data in the design of the studies that take your programs through to proof of concept.

At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects. We partner with Cognitive Research Corporation to use their proprietary driving simulators, nine of which are permanently installed in our clinic. We have performed well over 10,000 simulated drives to date.